NeuroPace Director Accumulates 15,594 Shares Through Quarterly Stock Payments

[Form 4] Neuropace, Inc. Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

NeuroPace director Rakhi Kumar reported multiple acquisitions of common stock between June 2023 and June 2025, received as compensation under the company's non-employee director compensation policy in lieu of quarterly retainer fees.

Key transaction details:

Total shares accumulated: 15,594 shares
Purchase prices ranged from $4.49 to $13.20 per share
Largest single acquisition: 3,340 shares on June 30, 2023
Most recent acquisition: 1,440 shares at $10.41 on June 21, 2025

All transactions were direct acquisitions, with shares held in direct ownership. The consistent pattern of quarterly acquisitions suggests regular board compensation practices, with share quantities varying based on the prevailing stock price at each grant date.

06/24/2025 - 04:30 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kumar Rakhi

(Last)

(First)

(Middle)

C/O NEUROPACE, INC.

455 N. BERNARDO AVENUE

(Street)

MOUNTAIN VIEW

94043

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
NeuroPace Inc [ NPCE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/30/2023		A		3,340⁽¹⁾	A	$4.49	3,340	D
Common Stock	09/29/2023		A		1,541⁽¹⁾	A	$9.73	4,881	D
Common Stock	12/29/2023		A		1,454⁽¹⁾	A	$10.31	6,335	D
Common Stock	03/29/2024		A		1,136⁽¹⁾	A	$13.2	7,471	D
Common Stock	06/28/2024		A		1,984⁽¹⁾	A	$7.56	9,455	D
Common Stock	09/30/2024		A		2,152⁽¹⁾	A	$6.97	11,607	D
Common Stock	12/21/2024		A		1,300⁽¹⁾	A	$11.53	12,907	D
Common Stock	03/21/2025		A		1,247⁽¹⁾	A	$12.02	14,154	D
Common Stock	06/21/2025		A		1,440⁽¹⁾	A	$10.41	15,594	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

	/s/ Leah Akin, Attorney-in-Fact	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many shares of NPCE stock did Director Rakhi Kumar acquire in June 2025?

According to the Form 4 filing, Director Rakhi Kumar acquired 1,440 shares of NPCE common stock on June 21, 2025, at a price of $10.41 per share.

What is the total number of NPCE shares owned by Rakhi Kumar after the latest transaction?

Following the most recent transaction on June 21, 2025, Rakhi Kumar beneficially owned a total of 15,594 shares of NPCE common stock directly.

Why did NPCE Director Rakhi Kumar receive these shares?

According to the filing's explanation of responses, these shares were issued to Kumar pursuant to NeuroPace's non-employee director compensation policy in lieu of quarterly retainer fees.

How has the share acquisition price for NPCE Director Kumar changed over the reported period?

The share acquisition price has fluctuated significantly: starting at $4.49 in June 2023, rising to $13.20 in March 2024, dropping to $6.97 in September 2024, and most recently settling at $10.41 in June 2025.

What was the largest single acquisition of NPCE shares by Kumar during the reported period?

The largest single acquisition was 3,340 shares on June 30, 2023, at a price of $4.49 per share.

AG真人官方

[Form 4] Neuropace, Inc. Insider Trading Activity

FAQ

How many shares of NPCE stock did Director Rakhi Kumar acquire in June 2025?

What is the total number of NPCE shares owned by Rakhi Kumar after the latest transaction?

Why did NPCE Director Rakhi Kumar receive these shares?

How has the share acquisition price for NPCE Director Kumar changed over the reported period?

What was the largest single acquisition of NPCE shares by Kumar during the reported period?

NASDAQ:NPCE

NPCE Rankings

NPCE Latest News

NPCE Latest SEC Filings

NPCE Stock Data

AG真人官方

Trending News

[Form 4] Neuropace, Inc. Insider Trading Activity

FAQ

How many shares of NPCE stock did Director Rakhi Kumar acquire in June 2025?

What is the total number of NPCE shares owned by Rakhi Kumar after the latest transaction?

Why did NPCE Director Rakhi Kumar receive these shares?

How has the share acquisition price for NPCE Director Kumar changed over the reported period?

What was the largest single acquisition of NPCE shares by Kumar during the reported period?

NASDAQ:NPCE

NPCE Rankings

NPCE Latest News

NPCE Latest SEC Filings

NPCE Stock Data